We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Primavera Capital Acquisition Corporation | NYSE:PV | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.90 | 0 | 00:00:00 |
By Ian Walker
Reckitt Benckiser Group PLC said it is selling its infant-formula and child-nutrition business in China to Primavera Capital Acquisition Corp. for $1.3 billion net.
The consumer-goods company--which houses Dettol, Harpic and Durex among its brands--said Saturday the enterprise value of the deal is $2.2 billion.
The sale follows a review of the business in February, Reckitt said, adding that it will continue to hold an 8% interest in the unit.
The sale is expected to be completed in the second half of this year, it said.
Reckitt said it expects to incur tax costs of around 300 million pounds ($424.7 million) and other costs of GBP200 million. The net proceeds of the sale will be used to cut debt, it said.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
June 07, 2021 02:10 ET (06:10 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Primavera Capital Acquis... Chart |
1 Month Primavera Capital Acquis... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions